Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Aug;25(8):1287-1290.
doi: 10.1016/j.drudis.2020.06.022. Epub 2020 Jun 25.

Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders

Bruno O Villoutreix  1 , Philippe H Beaune  2 , Ryad Tamouza  3 , Rajagopal Krishnamoorthy  3 , Marion Leboyer  4
Affiliations
Editorial

Prevention of COVID-19 by drug repurposing: rationale from drugs prescribed for mental disorders

Bruno O Villoutreix et al. Drug Discov Today. 2020 Aug.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Potential effects of psychotropic drugs on SARS-CoV-2. This very simplified cartoon highlights SARS-CoV-2 cell entry. Angiotensin-converting enzyme 2 receptor (ACE2), Acetylcholine receptor (nAChR), Transmembrane surface serine protease (TMPRSS2). Some graphical elements were taken from the free medical art collection distributed by the Servier laboratory.
See this image and copyright information in PMC

Comment in

References

    1. Salata C. Antiviral activity of cationic amphiphilic drugs. Expert Rev. Anti. Infect. Ther. 2017;15(5):483–492. - PMC - PubMed
    1. Ekins S. Deja vu: Stimulating open drug discovery for SARS-CoV-2. Drug Discov. Today. 2020 - PMC - PubMed
    1. Johansen L.M. A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activity. Sci. Transl. Med. 2015;7(290) - PubMed
    1. Dyall J. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob. Agents Chemother. 2014;58(8):4885–4893. - PMC - PubMed
    1. Muehlbacher M. Identification of drugs inducing phospholipidosis by novel in vitro data. ChemMedChem. 2012;7(11):1925–1934. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources